<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>arthralgia &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/arthralgia/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Oct 2026 07:19:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>arthralgia &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Persistent symptoms common after Ebola and chikungunya across Africa, review finds</title>
		<link>https://bioengineer.org/persistent-symptoms-common-after-ebola-and-chikungunya-across-africa-review-finds/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 24 Oct 2026 07:19:30 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[arthralgia]]></category>
		<category><![CDATA[Beyond]]></category>
		<category><![CDATA[chikungunya]]></category>
		<category><![CDATA[Ebola virus disease]]></category>
		<category><![CDATA[fatigue]]></category>
		<category><![CDATA[Global Health Security]]></category>
		<category><![CDATA[Long COVID]]></category>
		<category><![CDATA[ocular complications]]></category>
		<category><![CDATA[post-acute infection syndromes]]></category>
		<category><![CDATA[survivor care]]></category>
		<category><![CDATA[systematic review]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=451318</guid>

					<description><![CDATA[A systematic review of 65 African studies reports persistent symptoms in 17.5 to 98.6 percent of Ebola survivors and 12.1 to 78.6 percent of chikungunya survivors, with pain, fatigue and joint problems lasting years after acute infection.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">451318</post-id>	</item>
	</channel>
</rss>
